Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.3.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.3.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LV.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LV.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LV.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HK.23NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HK.23NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.23NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GE.1.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GE.1.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GE.1.2.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
V.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
V.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
V.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.149NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.149NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.149NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.413NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.413NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.413NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.258.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.258.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.258.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.9.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.9.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.9.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.107NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.107NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.107NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.10NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.10NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.9NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.9NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.4.10 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-1668.53US
AY.4.10 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.4.10 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-3660.47China
B.47NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.47NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.47NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.36.16NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.36.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.16NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.41 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.41 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.41 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.71NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.71NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used